SEI Investments’s iShares Biotechnology ETF IBB Stock Holding History

SEI Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,000	Closed	-$410K	–	2446
2020 Q2	$410K	Sell	3,000 -61	-2%	-$7.78K	﹤0.01%	1931
2020 Q1	$330K	Buy	3,061 +61	+2%	+$7.02K	﹤0.01%	1884
2019 Q4	$362K	Hold	3,000	–	–	﹤0.01%	2069
2019 Q3	$299K	Hold	3,000	–	–	﹤0.01%	2122
2019 Q2	$327K	Hold	3,000	–	–	﹤0.01%	2091
2019 Q1	$335K	Buy	+3,000	New	+$329K	﹤0.01%	2074
2018 Q3	–	Sell	-5,625	Closed	-$618K	–	2906
2018 Q2	$618K	Buy	5,625 +255	+5%	+$27.3K	﹤0.01%	1750
2018 Q1	$573K	Buy	5,370 +3,471	+183%	+$385K	﹤0.01%	1587
2017 Q4	$203K	Buy	1,899 +579	+44%	+$61.9K	﹤0.01%	1912
2017 Q3	$147K	Buy	1,320 +231	+21%	+$24.7K	﹤0.01%	1970
2017 Q2	$113K	Sell	1,089 -114	-9%	-$11.2K	﹤0.01%	2034
2017 Q1	$118K	Buy	1,203 +900	+297%	+$86.2K	﹤0.01%	1894
2016 Q4	$27K	Hold	303	–	–	﹤0.01%	2281
2016 Q3	$29K	Buy	303 +123	+68%	+$11.7K	﹤0.01%	2187
2016 Q2	$15K	Buy	+180	New	+$16.1K	﹤0.01%	2205

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SEI Investments's IBB Position: Q3 2020 in Review

SEI Investments sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 3,000 shares — an estimated $410K sold.

SEI Investments first reported a position in IBB in Q2 2016 and held it in 15 quarters. The position peaked at $618K in Q2 2018. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

SEI Investments reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
SEI Investments sold 3,000 iShares Biotechnology ETF shares in Q3 2020, an estimated $410K.
SEI Investments first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 15 quarters.
SEI Investments's iShares Biotechnology ETF position peaked at $618K in Q2 2018.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on SEI Investments's 13F filing for Q3 2020, filed 6 Nov 2020.